Clinical Trials Browser

Phase 4 × Prostatic Neoplasms × Genitourinary × Clear all

NCT04108208 2026-03-16

A Study of Apalutamide in Chinese Participants With Non Metastatic Castration Resistant Prostate Cancer (NM-CRPC)

Phase 4 Active not recruiting

75 enrolled 9 charts

Prostatic Neoplasms

NCT05700903 2026-03-02

ARCH

Phase 4 Completed

Hypertension, Kidney Diseases, Prostatic Neoplasms, Primary Dysautonomias

NCT03016741 2026-02-24

Cognitive Effects of Androgen Receptor Directed Therapies for Advanced Prostate Cancer

Phase 4 Active not recruiting

Dementia, Prostatic Neoplasms, Cognitive Dysfunction, Prostatic Neoplasms, Castration-Resistant

NCT07278362 2026-02-23

Testosterone Replacement Therapy in Hypogonadal Patients With Prostate Cancer Under Active Surveillance

Phase 4 Not yet recruiting

Eunuchism, Prostatic Neoplasms

NCT06627530 2026-02-11

COAction

Phase 4 Active not recruiting

Prostatic Neoplasms

NCT06733350 2026-02-09

Testosterone Replacement Therapy for the Treatment of Low Testosterone in Hypogonadal Men With Localized Prostate Cancer on Active Surveillance

Phase 4 Suspended

Prostatic Neoplasms

NCT07252726 2026-02-09

Evaluating Dose Timing (Morning vs Evening) of Endocrine-based Therapies in Metastatic Breast and Prostate Cancers

Phase 4 Recruiting

BreastGenitourinary

Breast Neoplasms, Neoplasm Metastasis, Prostatic Neoplasms

NCT05348876 2026-01-30

A Study to Learn More About How Safe Darolutamide is and How Well it Works Under Real World Conditions When Taken in Addition to Standard Androgen Deprivation Therapy (ADT) in Indian Participants With High-risk Non-metastatic Castration-resistant Prostate Cancer (nmCRPC)

Phase 4 Recruiting

Prostatic Neoplasms

NCT04373564 2026-01-22

ODYSSEY

Phase 4 Recruiting

BreastEndocrineGastrointestinalGenitourinaryNET

Breast Neoplasms, Carcinoma, Hepatocellular, Prostatic Neoplasms, Colorectal Neoplasms, Neuroendocrine Tumors

NCT06660862 2026-01-08

Evaluating Treatment Outcomes Using Darolutamide and Androgen Deprivation Therapy in Patients With Metastatic Hormone-Sensitive Prostate Cancer.

Phase 4 Not yet recruiting

Neoplasm Metastasis, Prostatic Neoplasms

NCT02651948 2025-12-19

Transperineal, MRI-guided, Prostate Biopsy

Phase 4 Completed

Prostatic Neoplasms

NCT05722925 2025-11-14

Evaluating Fluciclovine PET in Patients With Biochemical Recurrence of Prostate Cancer and a Negative PSMA PET

Phase 4 Active not recruiting

Prostatic Neoplasms

NCT06479187 2025-11-05

PSMAtrack-tracking Changes in PSMA-PET During Initial Therapy for Metastatic Hormone-sensitive Prostate Cancer

Phase 4 Active not recruiting

Prostatic Neoplasms

NCT06226129 2025-10-20

Gadopiclenol in Contrast Enhanced MRI of the Prostate

Phase 4 Recruiting

Prostatic Neoplasms

NCT06074510 2025-09-11

MIRROR

Phase 4 Active not recruiting

Prostatic Neoplasms

NCT06604442 2025-09-11

Intrapatient Comparison of Urinary Radioactivity Following Piflufolastat (18F) and Flotufolastat (18F) PET in Men With Low PSA Biochemical Recurrence of Prostate Cancer Following Radical Prostatectomy

Phase 4 Completed

Prostatic Neoplasms

NCT06908694 2025-07-29

GAINPCCONTROL

Phase 4 Recruiting

Prostatic Neoplasms

NCT07001709 2025-06-03

ENABLE

Phase 4 Recruiting

Cancer Pain, Prostatic Neoplasms

NCT05805436 2025-05-30

Preop Laxatives in Robotic Urologic Surgery

Phase 4 Recruiting

GenitourinaryOther

Constipation, Kidney Neoplasms, Prostatic Neoplasms

NCT05753046 2025-04-27

TAPBlock

Phase 4 Enrolling by invitation

Prostatic Neoplasms

NCT05803941 2025-04-24

Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer

Phase 4 Recruiting

Prostatic Neoplasms

NCT04134208 2025-01-16

An Investigational Scan (18F-Fluciclovine PET-CT) for the Measurement of Therapeutic Response in Patients With Metastatic Prostate Cancer

Phase 4 Terminated

2 enrolled 10 charts

Prostatic Neoplasms

NCT05568537 2025-01-03

Prostate MRI and Pylarify PSMA PET/CT

Phase 4 Withdrawn

Prostatic Neoplasms

NCT02918968 2024-12-09

Study on Enzalutamide and Flutamide in Patients With Castration Resistant Prostate Cancer

Phase 4 Completed

206 enrolled 16 charts

Prostatic Neoplasms

NCT06706921 2024-11-27

18F-Fluciclovine PET/CT Impact on Predicting Clinical Outcome of 177Lu-PSMA-617 Therapy in Patients With Prostate Cancer

Phase 4 Recruiting

Genital Diseases, Male, Genital Neoplasms, Male, Neoplasms, Neoplasms by Site, Prostatic Diseases, Prostatic Neoplasms, Urogenital Neoplasms, Male Urogenital Diseases, Prostatic Neoplasms, Castration-Resistant

NCT03035032 2024-11-26

A Study of ELIGARD® in Hormone-dependent Prostate Cancer Patients

Phase 4 Completed

107 enrolled 25 charts

Prostatic Neoplasms

NCT05629494 2024-10-18

ADAPT-PSA

Phase 4 Recruiting

Prostatic Neoplasms, Prostatitis

NCT01794793 2024-10-01

Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored Studies

Phase 4 Completed

337 enrolled 8 charts

DermatologicEndocrineGenitourinaryNET

Acromegaly, Dumping Syndrome, Melanoma, Neoplasms, Pituitary Neoplasms, Prostatic Neoplasms, Neuroendocrine Tumors, Pituitary ACTH Hypersecretion

NCT00953277 2024-08-12

Study of Nerve Reconstruction Using AVANCE in Subjects Who Undergo Robotic Assisted Prostatectomy for Treatment of Prostate Cancer

Phase 4 Completed

Prostatic Neoplasms, Peripheral Nerve Injuries

NCT05957822 2024-05-14

Goal-directed vs Preemptive Tranexamic Acid Administration in Non-cardiac Surgery

Phase 4 Recruiting

GastrointestinalGenitourinary

Hemorrhage, Liver Neoplasms, Prostatic Neoplasms, Seizures, Thromboembolism

NCT06258486 2024-02-26

Ultrasound Guided Inguinal Indocyanine Green Injection to Identify and Pre-emptively Seal Lymphatic Leaks

Phase 4 Unknown

Lymphocele, Prostatic Neoplasms

NCT03432949 2024-01-24

TRANCE

Phase 4 Unknown

Prostatic Neoplasms

NCT06144099 2024-01-02

Prothrombin Complex Concentrate vs Fresh Frozen Plasma in Goal-directed Bleeding Management in Non-cardiac Surgery

Phase 4 Unknown

Prostatic Neoplasms, Osteoarthritis, Hip, Spinal Dysraphism

NCT01995513 2023-09-18

PLATO

Phase 4 Completed

509 enrolled 18 charts

Prostatic Neoplasms

NCT06001619 2023-08-21

PROMED

Phase 4 Recruiting

Prostatic Hyperplasia, Prostatic Neoplasms

NCT05957653 2023-07-24

Lidocaine Combined With Sufentanil for Preventing Catheter-related Bladder Discomfort

Phase 4 Unknown

Prostatic Neoplasms

NCT03796195 2023-01-25

(SGB) in Men Treated for Prostate Cancer Improve Hot Flashes

Phase 4 Terminated

1 enrolled 9 charts

Prostatic Neoplasms, Hot Flashes

NCT05631080 2022-11-30

Transurethral Prostate Enucleation in Surveillance Protocol for Low Risk Prostate Cancer

Phase 4 Unknown

Urinary Bladder Neck Obstruction, Prostatic Neoplasms

NCT04074460 2022-06-09

VAPOR-C

Phase 4 Completed

BreastDermatologicGastrointestinalGenitourinaryThoracic

Breast Neoplasms, Colonic Neoplasms, Lung Neoplasms, Melanoma, Neoplasms, Prostatic Neoplasms

NCT03228108 2022-05-10

pro-SWAP

Phase 4 Completed

Infections, Prostatic Neoplasms

NCT05304169 2022-03-31

PRIZE

Phase 4 Completed

Prostatic Neoplasms

NCT02726009 2021-12-15

A Trial to Evaluate Safety of Firmagon® (Degarelix) in Indian Patients Diagnosed With Advanced Hormone-dependent Prostate Cancer

Phase 4 Completed

Prostatic Neoplasms

NCT05068180 2021-10-06

Low-dose Neuroleptanalgesia for Postoperative Delirium in Elderly Patients

Phase 4 Unknown

GastrointestinalGenitourinary

Emergence Delirium, Urinary Bladder Neoplasms, Colonic Neoplasms, Kidney Neoplasms, Liver Neoplasms, Prostatic Neoplasms, Rectal Neoplasms, Sigmoid Neoplasms, Stomach Neoplasms, Fractures, Bone

NCT04248621 2021-07-29

Androgen Deprivation Therapy on Bone Mineral Density Change in Prostate Cancer Patients

Phase 4 Unknown

Prostatic Neoplasms

NCT04882618 2021-05-12

Use of Indocyanine Green During Pelvic Lymph Node Dissection in Prostate Cancer.

Phase 4 Unknown

Lymphatic Metastasis, Prostatic Neoplasms

NCT04776889 2021-03-02

The Prognosis of Lipid Reprogramming With Rosuvastatin, in Castrated Egyptian Prostate Cancer Patients

Phase 4 Completed

Prostatic Neoplasms, Hypoalphalipoproteinemias

NCT01770340 2021-02-21

Nerve Grafting With an Allograft During Radical Prostatectomy - Extended Follow-up in a Prospective Randomized Trial

Phase 4 Terminated

Prostatic Neoplasms

NCT01753297 2020-12-09

PRIORITI

Phase 4 Completed

226 enrolled 19 charts

Prostatic Neoplasms

NCT03006562 2020-08-05

PREVENTER

Phase 4 Terminated

501 enrolled 13 charts

Classical hematologyGenitourinary

Prostatic Neoplasms, Pulmonary Embolism, Venous Thrombosis, Venous Thromboembolism

NCT02812186 2020-04-08

Deep Versus Moderate Neuromuscular Blockade During Laparoscopic Surgery

Phase 4 Completed

79 enrolled 9 charts

GenitourinaryGynecologic

Cholecystitis, Endometriosis, Intestinal Obstruction, Leiomyoma, Prostatic Neoplasms, Uterine Prolapse, Renal Insufficiency, Chronic